VIDO-InterVac Director and CEO Dr. Volker Gerdts joins Global News Morning to discuss where $59 million in federal funding will go to, along with an update on their vaccine trial.
Global News Morning Saskatoon
VIDO-InterVac on new federal funding, vaccine trial
More Videos
You are viewing an Accelerated Mobile Webpage.
View Original Article